Investigation of the Prevalence of Human Papilloma Virus and Endocervical Sampling in Cervical Cytology Abnormalities–Case-Control Study

Year 2022, , 37 - 42, 31.08.2022

İsa Kaplan

https://doi.org/10.35514/mtd.2022.68

Abstract

AİM: Cervical cancer is the fourth most common and preventable cancer. For this reason, many scanning programs have been developed. In this study, we aimed to determine the prevalence of abnormal endocervical pathology and Human Papilloma Virus (HPV) and the importance of endocervical sampling in abnormal cervical cytology.
MATERİALS-METHODS: Our study was conducted in Aydın Adnan Menderes University Hospital between January 2013 and April 2016. 215 patients with abnormal cervical cytology who underwent HPV DNA screening and endocervical sampling were compared with 175 control group patients. Cervical cytology was interpreted according to the Bethesda 2001 classification system. Statistical analysis was performed with SPSS 18.0 for the Windows program.
RESULTS: Our study was conducted with 390 patients with 215 (55%) abnormal Pap smears and 175 (45%) normal Pap smear results. The mean age of the cases was 45.5±9. The prevalence of HPV was 68.8% and the prevalence of abnormal endocervical pathology was 40% in cases with abnormal smear results. The prevalence of HPV positivity in the control group with normal smear was 53.7%. The prevalence of patients with abnormal endocervical sampling results was 2.8%. A significant correlation was found between cervical cytology abnormality and HPV DNA positivity (p=0.002). A significant correlation was found between cervical cytology abnormality and abnormal endocervical sampling results (p˂0.001). As the degree of cervical cytology abnormality increased, it was observed that the frequency of endocervical sample abnormalities and HPV DNA positivity increased (p=0.002).
CONCLUSİON: HPV positivity was found to be associated with cervical cytology abnormality. A significant correlation was found between abnormal cervical cytology and abnormal endocervical pathology. As the degree of cervical cytology abnormality increased, it was determined that the frequency of endocervical sample abnormalities and HPV DNA positivity increased.

Keywords

Abnormal Smear, HPV, Endocervical Sampling, Cervical Cancer

Servikal Sitoloji Anormalliğinde Human Papilloma Virus ile Endoservikal Örnekleme Prevalansının Araştırılması–Vaka Kontrol Çalışması

Abstract

GİRİŞ: Servikal kanser dördüncü sıklıkta görülen ve önlenebilir bir kanserdir. Bu nedenle birçok tarama programı geliştirilmiştir. Çalışmamızda anormal servikal sitolojide anormal endoservikal patoloji ve Human Papilloma Virus (HPV) prevalansını ve endoservikal örneklemenin önemini saptamayı amaçlamış bulunmaktayız.
MATERYAL-METOD: Çalışmamız Ocak 2013 ve Nisan 2016 tarihleri arasında Aydın Adnan Menderes Üniversitesi Hastanesinde yapılmıştır. Çalışmamız HPV DNA bakılmış ve endoservikal küretaj ile örneklem yapılmış hastalar üzerinde yapılmıştır. Servikal sitoloji anormalliği olan hasta 215 hasta ile 175 kontrol grubu mevcuttur. Servikal sitoloji Bethesda 2001 sınıflandırma sistemine göre yorumlanmıştır. SPSS 18.0 for Windows programı ile istatiksel analiz yapılmıştır.
BULGULAR: Çalışmamız 390 olgu üzerinde yapılmıştır. 215(%55) hastada anormal Pap smear, 175 (%45) hastada normal Pap smear saptanmıştır. Olguların ortalama yaşı 45.5±9 olarak saptanmıştır. Anormal Pap smearli olgularda HPV pozitifliği prevalansı %68.8, endoservikal örneklem patoloji prevalansı %40 olarak bulundu. Kontrol grubunda HPV pozitifliği prevalansı %53.7 idi. Endoservikal örneklem sonucu anormal olan hastaların prevalansı %2.8’idi. Anormal smear sitolojisi ile HPV DNA pozitifliği arasında istatistiksel olarak anlamlı ilişki saptandı (p=0.002). Servikal sitoloji anormalliği ile anormal endoservikal örnekleme patoloji sonuçları karşılaştırıldığında sonuç istatistiksel olarak anlamlı bulundu (p˂0.001). Servikal sitoloji anormalliğinin derecesi arttıkça endoservikal örneklem anormallikleri ve HPV DNA pozitifliğinin sıklığında artma olduğu görüldü (p=0.002).
SONUÇ: HPV pozitifliği servikal sitoloji anormalliği ile ilişkili bulunmuştur. Anormal servikal sitoloji ile anormal endoservikal patoloji arasında anlamlı ilişki bulunmuştur. Servikal sitoloji anormalliğinin derecesi arttıkça endoservikal örneklem anormallikleri ve HPV DNA pozitifliğinin sıklığında artma olduğu saptanmıştır.

Keywords

Anormal Smear, HPV, Endoservikal Örnekleme, Serviks Kanseri

References

• 1. Sawaya GF, Smith-McCune K. Cervical Cancer Screening. Obstet Gynecol. 2016 Mar;127(3):459-467. doi: 10.1097/AOG.0000000000001136. PMID: 26855089; PMCID: PMC6585413.
• 2. Mattiuzzi C, Lippi G. Current Cancer Epidemiology. J Epidemiol Glob Health. 2019 Dec;9(4):217-222. doi: 10.2991/jegh.k.191008.001. PMID: 31854162; PMCID: PMC7310786.
• 3. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003 Jan;16(1):1-17. doi: 10.1128/CMR.16.1.1-17.2003. PMID: 12525422; PMCID: PMC145302.
• 4. Ferlay J, Soerjomataram I, Dikshit R et all. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9. PMID: 25220842.
• 5. E. J. Mayeaux Jr, J.Thomas Cox, Modern Kolposkopi Konu El Kitabı Güneş Tıp 2014.
• 6. Sağlık Bakanlığı, yıl bazında kanser istatistikleri, kadınlarda en çok görülen 10 kanser türü, 2014 (http://www.saglik.gov.tr, http://www.tkhk.gov.tr/Dosyalar/9cbd459370024ac6a19d7bc 0f23aae8.pdf )
• 7. Janet G. BasemanLaura A. Koutsky The epidemiology of human Papillomavirus infections Journal of Clinical Virology 2005 vol:32 p:16-24.
• 8.Koushik Chattopadhvay A comprehensive review on host genetic susceptibility to human Papillomavirus infection and progression to cervical cancer İndian Journal Genetic 2011 17(3): 132-144.
• 9. Jill Koshiol, Lisa Lindsay, Jeanne M et all. Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-Analysis Am J Epidemiol. 2008 Jul 15; 168(2): 123–137.
• 10. Kevin A. Ault Epidemiology and Natural History of Human Papillomavirus Infections in the Female Genital Tract Infectious Diseases in Obstetrics and Gynecology Volume 2006, Article ID 40470, Pages 1–5.
• 11. Mark H Stoler MD, Realistic Estimates from ASCUS-LSIL Triage Study İnterobserver Reproducilibility of cervical cytologic and histolojic interpretations JAMA 2001 Vol:285 No:11.
• 12. Mark E. Sherman MD, Diane Solomon et all for the ALTS Group A Comparison of Equivocal LSIL and Equivocal HSIL Cervical Cytology in the ASCUS LSIL Am J Clin Pathol2001; 116: 386-394.
• 13. Dursun P, Senger SS, Arslan H et all. Human Papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. BMC Infect Dis, 2009; 9: 191.
• 14. Sabit Sinan Özalp, Tercan Us, Emine Arslan et all. HPV DNA and Pap smear test results in cases with and without cervical pathology J Turk Ger Gynecol Assoc. 2012; 13(1): 8-14.
• 15. M.M. Inal, Ş.Köse, Y. Yıldırım et all. The relationship between human Papilloma virus infection and cervical intraepithelial neoplasia in Turkish women Int J Gynecol Cancer 2007, 17, 1266-1270.
• 16. Faruk Abike, Banu Bingöl, Ali Yılmaz et all. HPV Infection and HPV Subtypes in Normal and Abnormal Cervical Cytology in Turkish Women IBIMA Publishing Journal of Virology & Microbiology Vol. 2013 (2013), Article ID 640873, 7 pages.
• 17. Sotirios Tsiodras, John Georgoulakis, Aikaterini Chranioti et al. Hybrid capture vs. PCR screening of cervical human Papilloma virus infections. Cytological and histological associations in 1270 women Tsiodras et al. BMC Cancer 2010, 10: 53.
• 18. Dr Victor Moreno, F Xavier Bosch, Nubia Muñoz et all. Walboomers Rolando Herrero, Silvia Franceschi for the International Agency for Research on Cancer (IARC) Multicentric Cervical Cancer Study GroupEffect of oral contraceptives on risk of cervical cancer in women with human Papillomavirus infection: the IARC multicentric case-control study The Lancet 2002 march Volume 359, No.9312 p1085-92.
• 19. Mar´ıa Guadalupe L´opez Rivera, Maria OliviaMedel Flores, Jos´e D’Artagnan Villalba et all. Prevalence of Human Papillomavirus in Women from Mexico City Infectious Diseases in Obstetrics and GynecologyVolume 2012 (2012), Article ID 384758, 4 pages.
• 20. Angela Pista PhD, Carlos Freire de Oliveira PhD, Maria Joa˜o Cunha MD et all. Prevalence of Human Papillomavirus Infection in Women in Portugal The CLEOPATRE Portugal Study Int J Gynecol Cancer 2011;21: 1150Y1158).
• 21. C. E. Depuydt, I. H. Benoy, E. J. Bailleul et all. Improved endocervical sampling and HPV viral load detection by Cervex-BrushCombi Cytopathology 2006, 17, 374–381 2006.
• 22. Lambert B, Bovoın Y, Lepage Y. Atypical squamous cells of undetermined significance (ASCUS): clinical-cytological significance International Journal of Gynecological Cancer: July/August 1999 - Volume 9 - Issue 4 - pp 329-332.
• 23. Moniak CW, Kutzner S, Adam E et all. Endocervical curettage in evaluating abnormal cervical cytology. J Reprod Med. 2000 Apr;45(4):285-92. PMID: 10804483.
• 24. Deha Denizhan Keskin, Seda Keskin, Ezgi Erdoğan ve ark. Endoservikal Küretaj: Minimal Servikal SitolojikAnormalliklerde Kolposkopik Muayene Normal veYeterli Olduğunda Yeni Tıp Dergisi 2014;31:177-179